Find potent antiviral drugs against SARS-CoV2 by targeting well identified proteins essential to the viral cycle (DrugDesign_SARS2 project)
- Funded by Institut Pasteur International Network (IPIN)
- Total publications:0 publications
Grant number: DrugDesign_SARS2
Grant search
Key facts
Disease
COVID-19Funder
Institut Pasteur International Network (IPIN)Principal Investigator
PendingResearch Location
France, ItalyLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The DrugDesign_SARS2 project aims to find effective antiviral drugs against SARS-CoV-2 that target proteins essential to the viral cycle. The project brings together the expertise of several laboratories and platforms of the Institut Pasteur International Network (Paris, Lille, Rome). The aim of the study is to examine a large number of compounds as quickly as possible using high throughput screening techniques. In a second round, the objective will be to improve the selected compounds, by chemical processes and using the data obtained by the various laboratories.